I agree that this site is using cookies. You can find further informations here.
X
Hu, Mimi I.
346  results:
Search for persons X
?
1

Reply to Letter to the Editor regarding "Decreased utilizat..:

Maniakas, Anastasios ; Hu, Mimi I. ; Gunn, G. Brandon.
Head & Neck.  46 (2024)  7 - p. 1848-1849 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Next-Generation Sequencing in Sporadic Medullary Thyroid Ca..:

Shirali, Aditya S ; Hu, Mimi I ; Chiang, Yi-Ju...
Journal of the Endocrine Society.  8 (2024)  6 - p. , 2024
Link: https://doi.org/10.1210/..
 
?
3

Clinical Activity of Selpercatinib in RET-mutant Pheochromo..:

Deschler-Baier, Barbara ; Konda, Bhavana ; Massarelli, Erminia...
The Journal of Clinical Endocrinology & Metabolism.  , 2024
Link: https://doi.org/10.1210/..
 
?
4

RET kinase inhibitors for the treatment of RET-altered thyr..:

Hamidi, Sarah ; Hu, Mimi I.
Annales d'Endocrinologie.  85 (2024)  2 - p. 118-126 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Pediatric Medullary Thyroid Carcinoma: Clinical Presentatio..:

Hensley, Sarah G ; Hu, Mimi I ; Bassett, Roland L...
The Journal of Clinical Endocrinology & Metabolism.  , 2024
Link: https://doi.org/10.1210/..
 
?
6

Decreasing utilization for postoperative radiation therapy ..:

Maniakas, Anastasios ; Sullivan, Andrew ; Hu, Mimi I....
Head & Neck.  46 (2023)  2 - p. 328-335 , 2023
Link: https://doi.org/10.1002/..
 
?
7

Strategies for mitigating adverse events related to selecti..:

Nardo, Mirella ; Gouda, Mohamed A. ; Nelson, Blessie E....
Cell Reports Medicine.  4 (2023)  12 - p. 101332 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Review article: new treatments for advanced differentiated ..:

Hamidi, Sarah ; Hofmann, Marie-Claude ; Iyer, Priyanka C....
Frontiers in Endocrinology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

Libretto-531: A Phase III Study of Selpercatinib in Multiki..:

Wirth, Lori J ; Brose, Marcia S ; Elisei, Rossella...
Future Oncology.  18 (2022)  28 - p. 3143-3150 , 2022
Link: https://doi.org/10.2217/..
 
?
10

RET kinase inhibitors forRET-altered thyroid cancers:

Vodopivec, Danica M. ; Hu, Mimi I.
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211016 , 2022
Link: https://doi.org/10.1177/..
 
?
11

Treatment of Hypercalcemia of Malignancy in Adults: An Endo..:

El-Hajj Fuleihan, Ghada ; Clines, Gregory A ; Hu, Mimi I...
The Journal of Clinical Endocrinology & Metabolism.  108 (2022)  3 - p. 507-528 , 2022
Link: https://doi.org/10.1210/..
 
?
12

Adverse events associated with bone-directed therapies in p..:

Jara, Mark A. ; Varghese, Jeena ; Hu, Mimi I.
Bone.  158 (2022)  - p. 115901 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Hypercalcemia of Malignancy:

Hu, Mimi I.
Endocrinology and Metabolism Clinics of North America.  50 (2021)  4 - p. 721-728 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Immune checkpoint inhibitor related hypophysitis: diagnosti..:

Nguyen, Ha ; Shah, Komal ; Waguespack, Steven G...
Endocrine-Related Cancer.  28 (2021)  7 - p. 419-431 , 2021
Link: https://doi.org/10.1530/..
 
?
15

Decision Making When Cancer Becomes Chronic: Needs Assessme..:

Shojaie, Danielle ; Hoffman, Aubri S ; Amaku, Ruth...
JMIR Formative Research.  5 (2021)  7 - p. e27484 , 2021
Link: https://doi.org/10.2196/..
 
1-15